Joo WS - Search Results

1

Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats.

Joo WS, Jin BK, Park CW, Maeng SH, Kim YS. Joo WS, et al. Neuroreport. 1998 Dec 21;9(18):4123-6. doi: 10.1097/00001756-199812210-00022. Neuroreport. 1998. PMID: 9926859

2

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

Jin BK, Shin DY, Jeong MY, Gwag MR, Baik HW, Yoon KS, Cho YH, Joo WS, Kim YS, Baik HH. Jin BK, et al. Among authors: joo ws. Neurosci Lett. 1998 Apr 3;245(2):61-4. doi: 10.1016/s0304-3940(98)00170-0. Neurosci Lett. 1998. PMID: 9605485

3

Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system.

Kim YS, Joo WS, Jin BK, Cho YH, Baik HH, Park CW. Kim YS, et al. Among authors: joo ws. Neuroreport. 1998 Jul 13;9(10):2387-90. doi: 10.1097/00001756-199807130-00043. Neuroreport. 1998. PMID: 9694233

4

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.

Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH. Park HJ, et al. Among authors: joo ws. Exp Neurol. 2003 Mar;180(1):93-8. doi: 10.1016/s0014-4886(02)00031-6. Exp Neurol. 2003. PMID: 12668152

5

Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum.

Nam E, Lee SM, Koh SE, Joo WS, Maeng S, Im HI, Kim YS. Nam E, et al. Among authors: joo ws. Brain Res. 2005 Jun 7;1046(1-2):90-6. doi: 10.1016/j.brainres.2005.03.053. Brain Res. 2005. PMID: 15882841

6

Baicalein prevents 6-hydroxydopamine-induced dopaminergic dysfunction and lipid peroxidation in mice.

Im HI, Joo WS, Nam E, Lee ES, Hwang YJ, Kim YS. Im HI, et al. Among authors: joo ws. J Pharmacol Sci. 2005 Jun;98(2):185-9. doi: 10.1254/jphs.sc0050014. Epub 2005 Jun 8. J Pharmacol Sci. 2005. PMID: 15942123 Free article.

7

Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease.

Park S, Kim EY, Ghil GS, Joo WS, Wang KC, Kim YS, Lee YJ, Lim J. Park S, et al. Among authors: joo ws. Neurosci Lett. 2003 Dec 19;353(2):91-4. doi: 10.1016/j.neulet.2003.08.082. Neurosci Lett. 2003. PMID: 14664908

8

General pharmacology of indole [2',3':3,4]pyrido[2,1-b]quinazolinium- 5,7,8,13-tetrahydro-14-methyl-5-oxo-chloride, a new anti-dementia agent.

Park CH, Choi SH, Kim CH, Seo JH, Koo JW, Rah JC, Kim HS, Jeong SJ, Joo WS, Lee YJ, Kim YS, Kim MS, Suh YH. Park CH, et al. Among authors: joo ws. Arzneimittelforschung. 2003;53(6):393-401. doi: 10.1055/s-0031-1297126. Arzneimittelforschung. 2003. PMID: 12872609

9

The activation of ERK1/2 via a tyrosine kinase pathway attenuates trail-induced apoptosis in HeLa cells.

Lee MW, Bach JH, Lee HJ, Lee DY, Joo WS, Kim YS, Park SC, Kim KY, Lee WB, Kim SS. Lee MW, et al. Among authors: joo ws. Cancer Invest. 2005;23(7):586-92. doi: 10.1080/07357900500283036. Cancer Invest. 2005. PMID: 16305985

10

Mitogen-activated protein kinase/extracellular signal-regulated kinase attenuates 3-hydroxykynurenine-induced neuronal cell death.

Lee HJ, Bach JH, Chae HS, Lee SH, Joo WS, Choi SH, Kim KY, Lee WB, Kim SS. Lee HJ, et al. Among authors: joo ws. J Neurochem. 2004 Feb;88(3):647-56. doi: 10.1111/j.1471-4159.2004.02191.x. J Neurochem. 2004. PMID: 14720214 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters